We are proud to bring you Volume 15-2 of the Bangkok Medical Journal with contributions frommedical professionals on preventive health care and first of its kind surgical technology and innovation.
Globally, TB is one of the top 10 causes of mortality and the primary cause from a single infectiousagent over and above HIV/AIDS. Hence, to efficiently reduce the high rate of unidentified Latent TBcases that might lead to active TB in the future; a unified, well implemented, and sophisticated approachis crucial. Dr Sawang Saenghirunvattana, et al present a clinical series, which to our knowledge, is thefirst to report 20% conversion of QFT-Plus among LTB participants prescribed with a nine-monthIsoniazid prophylaxis. As there is no gold standard in the definition of conversion and reversion, furtherstudies are now needed to optimize the correlation between the efficacy of varied LTBI and TB treatmentregimen and conversion of QFT-Plus results.